Author
Listed:
- David Lyden
(Memorial Sloan-Kettering Cancer Center)
- Alison Z. Young
(Memorial Sloan-Kettering Cancer Center)
- David Zagzag
(Kaplan Cancer Center)
- Wei Yan
(Memorial Sloan-Kettering Cancer Center)
- William Gerald
(Memorial Sloan-Kettering Cancer Center)
- Richard O'Reilly
(Memorial Sloan-Kettering Cancer Center)
- Bernhard L. Bader
(Max-Planck-Institute for Biochemistry)
- Richard O. Hynes
(Massachusetts Institute of Technology)
- Yuan Zhuang
(Duke University Medical Center)
- Katia Manova
(Memorial Sloan-Kettering Cancer Center)
- Robert Benezra
(Memorial Sloan-Kettering Cancer Center)
Abstract
Id proteins may control cell differentiation by interfering with DNA binding of transcription factors. Here we show that targeted disruption of the dominant negative helix–loop–helix proteins Id1 and Id3 in mice results in premature withdrawal of neuroblasts from the cell cycle and expression of neural-specific differentiation markers. The Id1–Id3 double knockout mice also display vascular malformations in the forebrain and an absence of branching and sprouting of blood vessels into the neuroectoderm. As angiogenesis both in the brain and in tumours requires invasion of avascular tissue by endothelial cells, we examined the Id knockout mice for their ability to support the growth of tumour xenografts. Three different tumours failed to grow and/or metastasize in Id1+/-Id3-/- mice, and any tumour growth present showed poor vascularization and extensive necrosis. Thus, the Id genes are required to maintain the timing of neuronal differentiation in the embryo and invasiveness of the vasculature. Because the Id genes are expressed at very low levels in adults, they make attractive new targets for anti-angiogenic drug design.
Suggested Citation
David Lyden & Alison Z. Young & David Zagzag & Wei Yan & William Gerald & Richard O'Reilly & Bernhard L. Bader & Richard O. Hynes & Yuan Zhuang & Katia Manova & Robert Benezra, 1999.
"Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts,"
Nature, Nature, vol. 401(6754), pages 670-677, October.
Handle:
RePEc:nat:nature:v:401:y:1999:i:6754:d:10.1038_44334
DOI: 10.1038/44334
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:401:y:1999:i:6754:d:10.1038_44334. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.